Blueprint Medicines
Price & Volume
Stats
See more52W Range | $73.04-$129.65 |
Market Cap | $8.3B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $562.1M |
Revenue Growth (YoY) | 55.5% |
Gross Profit (12 Mos) | $542.3M |
Diluted EPS | -$2.51 |
News
See moreYahoo Finance • 16 hours ago
Vanguard Health Care Fund's Strategic Moves: Johnson & Johnson Takes Center Stage with 2. ...
Yahoo Finance • 17 days ago
Vascarta Announces Addition of Dr. Janet Loesberg to Leadership Team
Yahoo Finance • 26 days ago
BPMC Quantitative Stock Analysis
Yahoo Finance • 27 days ago
Sanofi completes $9.1 billion acquisition of Blueprint Medicines, Nasdaq delisting follows
About
CEO | Ms. Kathryn Haviland M.B.A. |
Address | 45 Sidney Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 682 |
